MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 135 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,205,257 | +52.9% | 56,185 | +141.9% | 0.00% | +50.0% |
| Q2 2023 | $5,364,975 | -28.4% | 23,225 | -24.9% | 0.00% | -33.3% |
| Q1 2023 | $7,491,406 | -73.3% | 30,923 | -68.0% | 0.00% | -70.0% |
| Q4 2022 | $28,064,273 | +1595.7% | 96,690 | +279.7% | 0.01% | +900.0% |
| Q3 2022 | $1,655,000 | +27.1% | 25,463 | +40.0% | 0.00% | 0.0% |
| Q2 2022 | $1,302,000 | -55.3% | 18,185 | -38.8% | 0.00% | 0.0% |
| Q1 2022 | $2,916,000 | +55.5% | 29,729 | +34.3% | 0.00% | 0.0% |
| Q4 2021 | $1,875,000 | +8.7% | 22,132 | +2.4% | 0.00% | 0.0% |
| Q3 2021 | $1,725,000 | +191.4% | 21,614 | +255.6% | 0.00% | – |
| Q2 2021 | $592,000 | -69.5% | 6,078 | -63.4% | 0.00% | -100.0% |
| Q1 2021 | $1,944,000 | +628.1% | 16,618 | +590.7% | 0.00% | – |
| Q4 2020 | $267,000 | -12.2% | 2,406 | -6.1% | 0.00% | – |
| Q3 2020 | $304,000 | +7.8% | 2,561 | +2.9% | 0.00% | – |
| Q2 2020 | $282,000 | -55.9% | 2,489 | -74.0% | 0.00% | – |
| Q1 2020 | $640,000 | +546.5% | 9,588 | +788.6% | 0.00% | – |
| Q4 2019 | $99,000 | -95.3% | 1,079 | -95.6% | 0.00% | -100.0% |
| Q3 2019 | $2,121,000 | +81.9% | 24,590 | +121.0% | 0.00% | – |
| Q2 2019 | $1,166,000 | -2.8% | 11,126 | +16.2% | 0.00% | – |
| Q1 2019 | $1,200,000 | +79.4% | 9,578 | +61.4% | 0.00% | – |
| Q4 2018 | $669,000 | -59.1% | 5,933 | -22.3% | 0.00% | -100.0% |
| Q3 2018 | $1,635,000 | -33.3% | 7,635 | -12.9% | 0.00% | 0.0% |
| Q2 2018 | $2,451,000 | -45.5% | 8,765 | -77.2% | 0.00% | -50.0% |
| Q1 2018 | $4,494,000 | +26335.3% | 38,478 | +20476.5% | 0.00% | – |
| Q4 2017 | $17,000 | -63.0% | 187 | -81.9% | 0.00% | – |
| Q3 2017 | $46,000 | +58.6% | 1,031 | -44.6% | 0.00% | – |
| Q1 2017 | $29,000 | +107.1% | 1,860 | +92.3% | 0.00% | – |
| Q4 2016 | $14,000 | +600.0% | 967 | +581.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |